PIC Therapeutics
Pre-clinicalDevelops small molecule therapies targeting the eIF4A RNA helicase for cancer and metabolic diseases.
Founded
2018
Focus
OncologyMetabolic
About
Develops small molecule therapies targeting the eIF4A RNA helicase for cancer and metabolic diseases.
Funding History
2Total raised: $40M
Series A$35MNovartis Venture FundMar 15, 2021
Seed$5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile